Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

This study is currently recruiting participants. (see Contacts and Locations)

Verified January 2015 by Dana-Farber Cancer Institute

Sponsor:

Information provided by (Responsible Party):

Nadine Tung, MD, Beth Israel Deaconess Medical Center

ClinicalTrials.gov Identifier:

NCT01670500

First received: August 16, 2012

Last updated: January 14, 2015

Last verified: January 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2016
Estimated Primary Completion Date:	October 2015 (Final data collection date for primary outcome measure)